Epizyme president becomes second new life science partner in five months at Atlas
September 29, 2014 at 14:43 PM EDT
Less than a month after Cambridge oncology biotech Epizyme announced that its then-president and CFO Jason Rhodes would be leaving to join an unspecified local venture capital firm, Atlas Venture today announced that Rhodes is joining the firm this week as its fifth partner focused on life science companies...